Researchers
Pešić, Milica
Results 21-40 of 335
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Editorial on Special Issue: “Novel Therapeutic Strategies for Glioblastoma” | Podolski-Renić, Ana | Contribution to periodical | 21aM21a |
| 2025 | Personalized Genomic Analysis for Clinical Insights in Non-Small Cell Lung Cancer | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2025 | Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Koračak, Ljiljana; Ajdačić, Vladimir | Article | 21aM21a |
| 2025 | Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures | Podolski-Renić, Ana | Article | 22M22 |
| 2025 | Two novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | Development of a Clinically Relevant Temozolomide-Resistant Human Glioblastoma A-172 Cell Line | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | The impact of a protein phosphatase 2A inhibitor on glioblastoma and neurodegeneration | Chigriai, Margarita; Pešić, Vesna | Conference Paper | Mp. category will be shown later |
| 2025 | A simple alginate-based 3D in vitro model for preclinical anticancer drug evaluation![]() | Petrović, Jelena | Conference Paper | Mp. category will be shown later |
| 2025 | Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells![]() | Stojković, Pavle | Article | 21aM21a |
| 2024 | Synthesis and anticancer activity of novel sclareol derivatives![]() | Ajdačić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2024 | Drug screening approaches for small-molecule compounds in cancer-targeted therapy | Zhao, Yelin; Yuan, Chenyu; Shi, Yuchen; Liu, Xiaohong; Luo, Liaoxin; Zhang, Li; Pesic, Milica S | Reviews | 21M21 |
| 2024 | Functional Diagnostics in Personalized Therapy for Non-Small Cell Lung Carcinoma | Podolski-Renić, Ana | Conference Paper | Mp. category will be shown later |
| 2024 | Hybrid Compounds of Sclareol and Doxorubicin, their Synthesis and Application | Pešić, Milica | Patent | Mp. category will be shown later |
| 2024 | Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors | Dinić, Jelena | Article | 21M21 |
| 2024 | Synthesis of Artesunate-Pyrimidine Hybrids and Evaluation of Their Activity Against Multidrug-Resistant Cancer Cells | Koračak, Ljiljana; Selaković, Milica | Conference Paper | Mp. category will be shown later |
| 2024 | Advancements in Personalized Therapy for Non-Small Cell Lung Carcinoma: The Role of Functional Diagnostics![]() | Dinić, Jelena | Conference Paper | Mp. category will be shown later |
| 2024 | Editorial: Natural products and nanoparticles in cancer treatment: is there a light at the end of the tunnel?![]() | Pesic, Milica | Contribution to periodical | 21aM21a |
| 2024 | Development of a Biomimetic Platform for 3D Cancer Cell Cultures![]() | Obradović, Bojana | Conference Paper | Mp. category will be shown later |
| 2024 | Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma![]() | Stepanović, Ana | Article | 21a+M21a+ |
| 2024 | Plant-Based Products Originating from Serbia That Affect P-glycoprotein Activity![]() | Dinić, Jelena | Article | 21M21 |
